EP. 1: Defining Venous Thromboembolism and Medically Ill Patients
EP. 2: Identifying System Level Risk Measurement and Risk Scores
EP. 3: Length of Risk and Heparin or Mechanical Compression's Role
EP. 4: Risks of Symptomatic vs Asymptomatic Clots
EP. 5: Role of Biomarkers, Lifestyle Modifications, and LMWH at Discharge
EP. 6: Review of APEX and MARINER Trials
EP. 7: MAGELLAN Trial Review and the Risk of Bleeding
EP. 8: Assessment of Risk for VTE and Risk of Bleeding
EP. 9: Long-Term Anticoagulant Therapy
EP. 10: Factor Xa Inhibitor Dosing in Medically Ill Patients
EP. 11: Reducing the Burden of VTE
EP. 12: Future of Thromboprophylaxis and Final Thoughts
